Date Title
Sep 01, 2021
Olink to present at two upcoming investor conferences
Aug 31, 2021
CellCarta expands its biomarker capabilities for clinical trials by adding Olink technology to its global services
Aug 11, 2021
Olink reports second quarter 2021 financial results
Jul 27, 2021
Olink: CORAL to use the Olink Proteomics platform to identify novel protein biomarkers and biological mechanisms for neurological diseases
Jul 21, 2021
UK Biobank-PPP expands proteomics study of 53,000 participants to Olink Explore 3072
Jul 14, 2021
Olink Holding AB (publ) Announces Pricing of Public Offering of American Depositary Shares by Selling Shareholders
Jul 13, 2021
Olink enters into an agreement with deCODE genetics for early access to the Olink Explore 3072 Platform
Jul 12, 2021
Olink announces preliminary financial results for the second quarter 2021
Jul 12, 2021
Olink Holding AB (publ) Launches Public Offering of American Depositary Shares by Selling Shareholders
Jun 23, 2021
Olink announces the new Explore 3072 high throughput proteomics platform, offering uncompromised data quality with coverage of all major biological pathways
Displaying 1 - 10 of 17
Print Page
Print Page
Email Alerts
Email Alerts
RSS Feeds
RSS Feeds
Contact IR
Contact IR
Search
Search